Thymalfasin therapy accelerates COVID-19 pneumonia rehabilitation through anti-inflammatory mechanisms

INTRODUCTION: Thymosin drugs are commonly used for the treatment of viral infections due to their immunomodulatory effects. The comprehensive clinical efficacy of Thymalfasin therapy for COVID-19 associated pneumonia is not yet fully researched, another issue, whether the use of thymosin drugs can r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zirui, Wang, Cong, Fei, Xiaohua, Wu, Haixing, Niu, Peiqin, Shen, Changxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518946/
https://www.ncbi.nlm.nih.gov/pubmed/37743481
http://dx.doi.org/10.1186/s41479-023-00116-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518946/
https://www.ncbi.nlm.nih.gov/pubmed/37743481
http://dx.doi.org/10.1186/s41479-023-00116-6

Ejemplares similares